Fact.MR – A Market Research and Competitive Intelligence Provider: The global hemostasis diagnostics market was valued at around US$ 2 Bn in 2020, and is expected to accelerate at a CAGR of 7% to double in valuation and top US$ 4 Bn by 2031.
Sales Of Point-Of-Care Testing Systems Are Forecast To Reach A Market Value Of Us$ 400 Mn By 2031.
Rise in prevalence of cardiovascular diseases, deep vein thrombosis, and genetic & acquired blood clotting disorders, and advanced healthcare facilities & infrastructure are expected to promote growth of market across the region over the forecast period.
Fact.MR – A Market Research and Competitive Intelligence Provider: The global hemostasis diagnostics market was valued at around US$ 2 Bn in 2020, and is expected to accelerate at a CAGR of 7% to double in valuation and top US$ 4 Bn by 2031. The market in the U.S was valued at around US$ 620 Mn in 2020.
Growing awareness regarding hemostasis is likely to enhance rate of diagnosis and preventive care management. This factor is expected to particularly increasing the testing volumes. Hemostasis diagnostics devices have come a long way from quantifying optical density of clots in a cuvette to detection of clotting factors.
Hemostasis diagnostics help identify hemostatic defects that cause excessive bleeding. Rising incidence of blood clotting in patients particularly who are more prone to losing excess blood from the body during surgeries is a major factor contributing to market growth.
For More Insights on this Market, Get A Sample Report!
https://www.factmr.com/connectus/sample?flag=S&rep_id=6742
Key Takeaways from Market Study
- China is expected to reach US$ 800 Mn in the hemostasis diagnostics market by the year 2031.
- The global hemostasis diagnostics market is expected to reach US$ 4 Bn by the year 2031.
- Point-of-Care testing systems are expected to witness a CAGR of 5% between 2021 and 2031.
- North America holds more than 50% of the market share.
“Point-of-Care testing systems are expected to dominate the hemostasis diagnostics market even in the forecast period” says a Fact.MR analyst.
Rise in prevalence of cardiovascular diseases, deep vein thrombosis, and genetic & acquired blood clotting disorders, and advanced healthcare facilities & infrastructure are expected to promote growth of market across the region over the forecast period.
Increased prevalence of various hemostasis disorders, presence of regional and international market players, and massive investments in R&D across the country are expected to notably contribute toward the country’s market.
Improving healthcare infrastructure, increasing focus of emerging and leading market players on developing markets, rise in number of hospitals, increase in incidence of cardiovascular diseases, and growing adoption of hemostasis diagnostics as part of the treatment of diseases are some of the key factors that have driven demand for hemostasis diagnostics in China.
To Gain In-Depth Insights on Hemostasis Diagnostics Market, Request Methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6742
Market Developments
The key participants in hemostasis diagnostics market include Sysmex Corporation, Thermo Fisher Scientific, Inc., Beckman Coulter Inc., Instrumentation Laboratory, Nihon Kohden Corporation, F. Hoffmann-La Roche Ltd., and likewise.
- Sysmex Corporation, in December 2018, did launch its next gen analyzers in hemostasis field, known as the Automated Blood Coagulation Analyzers CN-3000 and CN-6000.
- Horiba Medical, in 2019, came up with its new-fangled parameter called “Yumizen D-Dimer” for diagnosing pulmonary embolism and deep vein thrombosis.
Market Categorization as Per Hemostasis Diagnostics Industry Research
- Product
- Laboratory Systems
- Consumables
- Point-of-Care Testing Systems
- Test
- Prothrombin Test Time (PT)
- Activated Partial Thromboplastin Time (APTT)
- Fibrinogen Degradation Products (FDP)
- Activated Clotting Time
- Platelet Aggregation Test
- D Dimer
- End User
- Hemostasis Diagnostics at Hospital and Clinics
- Hemostasis Diagnostics at Research Institutes
- Hemostasis Diagnostics at Independent Diagnostic Laboratories
Key Points Covered in Hemostasis Diagnostics Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Demand for Hemostasis Diagnostics and How to Navigate
Interested to Procure The Data? Inquire here
https://www.factmr.com/connectus/sample?flag=EB&rep_id=6742
Recommendation on Key Winning Strategies More Valuable Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the global immunoassay market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights by product (laboratory systems, consumables, and point-of-care testing systems), by test (PT (Prothrombin Test Time), APTT (Activated Partial Thromboplastin Time), FDP (Fibrinogen Degradation Products), activated clotting time, platelet aggregation test, and D Dimer), by end-user (hospital aand clinics, research institutes, and independent diagnostic laboratories), and by region (North America, LATAM, Europe, East Asia, South Asia & Oceania, and MEA).
Explore Fact.MR’s Coverage on the Healthcare Domain
Endoscopy Procedures Estimates Market - Endoscopy Procedures Estimates Market Analysis by Application (Colonoscopy, Gastrointestinal (GI), Endoscopy, Laparoscopy, Bronchoscopy, Gastroscopy, Duodenoscopy, Cystoscopy), by Region - Global Forecast 2022-2032
Self-Administered Medication Market - Self-Administered Medication Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2022 to 2032
Tissue Expanders Market - Tissue Expanders Market Forecast, Trend Analysis & Competition Tracking – Global Market insights 2022 to 2032
Non-Invasive Aesthetic Treatment Market - Global Non-Invasive Aesthetic Treatment Market by Procedure (Injectables, Skin Rejuvenation, Other Procedures), End User (Hospital/ Surgery Center, MedSpa, Traditional Spa, HCP Owned Clinic) and by Region- 2022 to 2032
Sacroiliac Joint Fusion Market - Sacroiliac Joint Fusion Market Analysis by Indication (Degenerative Sacroiliitis, Sacral Disruption, Trauma), by Treatment Type (Sacroiliac Joint Fusion Surgery, Sacroiliac Joint Fusion Injections, RF Sacroiliac Joint Fusion Ablation), by End User & Regional Forecast 2022-2032
Cardiac Resynchronization Therapy Market - Cardiac Resynchronization Therapy Market Analysis by Product Type (CRT-Defibrillator, RT-Pacemaker), by End-user Type, by Region - Global Forecast 2022-2032
Laboratory Information Management System Market - Laboratory Information Management System Market Forecast by Component (Software, Services), Deployment Mode (On-Premise, Cloud-based, Web-based), End-User (Life Sciences, CROs, Petrochemical Refineries & Oil and Gas Industry, Chemical Industry, Food and Beverage & Agriculture Industries, Environmental Testing Laboratories, Other Industries) and by Region- 2022 to 2032
Home Infusion Therapy Market - Home Infusion Therapy Market by product (infusion pumps, intravenous sets, IV cannulas and needleless connectors) application (anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals and other applications), and by Region- 2022 to 2032
Omics Based Clinical Trials Market - Omics Based Clinical Trials Market by Phase Type (Phase 1, Phase 2, Phase 3, Phase 4), by Study Design Type (Interventional Studies, Observational Studies, Expanded Access Studies), by Indication (Oncology, Cardiology, Respiratory Diseases, Skin Diseases, CNS Diseases, Immunology, Genetic Diseases, Other Indications) and by Region- 2022 to 2032
Blood Ketone Meter Market - Blood Ketone Meter Market by Product Type (Blood Ketone Monitoring, Blood Glucose and Ketone Monitoring, Consumables), Application (Human, Veterinary), End-use, and Region -2022 to 2032
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000’s trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com